In Section A, members will receive distinct doses and schedules of oral ABBV-744 pill to identify Harmless dosing regimen. Added contributors will be enrolled with the discovered monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be given as "include-on" therapy. In Section C, contributors https://aleisterz110juf2.losblogos.com/profile